ATE383578T1 - Frühen diagnose von blasentumor in urinproben - Google Patents

Frühen diagnose von blasentumor in urinproben

Info

Publication number
ATE383578T1
ATE383578T1 AT01949312T AT01949312T ATE383578T1 AT E383578 T1 ATE383578 T1 AT E383578T1 AT 01949312 T AT01949312 T AT 01949312T AT 01949312 T AT01949312 T AT 01949312T AT E383578 T1 ATE383578 T1 AT E383578T1
Authority
AT
Austria
Prior art keywords
marker
early diagnosis
bladder tumor
urine samples
rna
Prior art date
Application number
AT01949312T
Other languages
English (en)
Inventor
Giorgio Stanta
Original Assignee
Macrochip S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macrochip S R L filed Critical Macrochip S R L
Application granted granted Critical
Publication of ATE383578T1 publication Critical patent/ATE383578T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514—CD4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
AT01949312T 2000-05-08 2001-05-04 Frühen diagnose von blasentumor in urinproben ATE383578T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI001002A IT1318504B1 (it) 2000-05-08 2000-05-08 Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina.

Publications (1)

Publication Number Publication Date
ATE383578T1 true ATE383578T1 (de) 2008-01-15

Family

ID=11444995

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01949312T ATE383578T1 (de) 2000-05-08 2001-05-04 Frühen diagnose von blasentumor in urinproben

Country Status (6)

Country Link
EP (1) EP1281087B1 (de)
AT (1) ATE383578T1 (de)
AU (1) AU2001270505A1 (de)
DE (1) DE60132323D1 (de)
IT (1) IT1318504B1 (de)
WO (1) WO2001086288A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1355158A1 (de) 2002-04-19 2003-10-22 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Diagnose von Entzündungserkrankungen und Infektionen unter Bestimmung des Phosphoproteins LASP-1 als Inflammationsmarker
US7217515B2 (en) 2002-09-30 2007-05-15 Chi Mei Foundation Medical Center HURP gene as a molecular marker for bladder cancer
DK2444505T3 (da) * 2004-07-23 2017-01-02 Pacific Edge Ltd Urinmarkører til påvisning af blærecancer
ES2304306B1 (es) * 2007-03-20 2009-07-07 Indas Biotech, S.L.U. Metodo de diagnostico y/o pronostico de cancer vesical.
GB201814040D0 (en) * 2018-08-29 2018-10-10 Oncologica Uk Ltd Testing and therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863726A (en) * 1993-11-12 1999-01-26 Geron Corporation Telomerase activity assays
JPH09262100A (ja) * 1996-03-27 1997-10-07 Mount Sinai School Medicine City Univ New York テロメラーゼ活性の存在を測定することによる尿試料中のヒト膀胱癌細胞の検出方法
US6489097B2 (en) * 1996-06-28 2002-12-03 Chugai Seiyaku Kabushiki Kaisha Method for the detection of telomerase activity
ATE245194T1 (de) * 1996-10-01 2003-08-15 Geron Corp Katalytische untereinheit der menschlichen telomerase
DE19757300A1 (de) * 1997-12-22 1999-06-24 Roche Diagnostics Gmbh Nachweis von Harnblasenkarzinom in einer Urinprobe

Also Published As

Publication number Publication date
WO2001086288A2 (en) 2001-11-15
DE60132323D1 (de) 2008-02-21
EP1281087A2 (de) 2003-02-05
EP1281087B1 (de) 2008-01-09
AU2001270505A1 (en) 2001-11-20
WO2001086288A3 (en) 2002-05-16
ITMI20001002A0 (it) 2000-05-08
ITMI20001002A1 (it) 2001-11-08
IT1318504B1 (it) 2003-08-27

Similar Documents

Publication Publication Date Title
RU2442171C2 (ru) Чипы на основе антител для определения множественных трансдукторов сигналов в редких циркулирующих клетках
SE0000538D0 (sv) Methods and kits for proximity probing
SE9601318D0 (sv) Method for nucleic acid analysis
DE60230672D1 (de) Nukleinsäureanreicherung
EP1288313A3 (de) System und Verfahren zum Testen von Nukleinsäuremolekülen
PT2280283E (pt) Células marcadas para uso como controlo funcional interno em ensaios de deteção de células raras
ATE420351T1 (de) Sonden mit affinitätsverschiebung zur quantifizierung von analytenpolynukleotiden
DE60142254D1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
EA200200698A1 (ru) Способ выделения рнк из фиксированных формалином и залитых в парафин образцов ткани
DK1461618T3 (da) Homogene immununoassays til flere allergener
ATE335815T1 (de) Isolierung von nukleinsäuren
ATE360092T1 (de) Nukleinsäureprimer und -sonden zur detektion onkogener humaner papillomaviren
ATE513851T1 (de) Menschliches gen zur fruchtbarkeit entscheidend
ATE383578T1 (de) Frühen diagnose von blasentumor in urinproben
NO20052553L (no) Cobalaminanalyse.
ATE538217T1 (de) Erkennung von ektopischen schwangerschaften
WO2003100006A3 (en) Method of improved prostate cancer detection
ATE372392T1 (de) Verfahren zur bestimmung der menge einer zielnukleinsäure in einer probe
DK1214447T3 (da) Påvisning af pyruvatkinase-isoenzymer i fæces
ATE533053T1 (de) Nicht-elispot-test
DE69604051D1 (de) Verfahren zum sensitiven nachweis von reverser transcriptase
DE602005024254D1 (de)
ATE427494T1 (de) Verfahren zur quantifizierung der akt-protein- expression
DK1057021T3 (da) Fremgangsmåde til måling af totalanalyt
DK1337849T3 (da) Fremgangsmåder og sammensætninger til at sortere og/eller bestemme mikroorganismer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties